Cellular therapy increases survival in recurring B-cell lymphoma: Clinical trial
A two-year follow-up clinical trial found that a new personalized cellular therapy treatment for relapsed or refractory B-cell lymphoma demonstrated strong safety and improved overall survival in patients, according to findings ...
Feb 27, 2024
0
0